Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Fredun Pharmaceuticals Ltd
Your Vote -
Buy
40.00%
Hold
40.00%
Sell
20.00%
40.00%
5 users have voted
Option Chain
Analyzes market sentiment, predicts Fredun Pharmaceuticals Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Fredun Pharma. - Announcement under Regulation 30 (LODR)-Change in Management
-
Fredun Pharma. - Revised Outcome.
-
Fredun Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Fredun Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Fredun Pharma. Q4 net profit jumps 56.58% at Rs 11.07 cr
-
Fredun Pharma. - Audited Results For The Quarter And Year Ended On 31St March, 2026.
-
Fredun Pharma. - Board Meeting Outcome for Outcome Of Board Meeting Held On 25Th May, 2026
-
Fredun Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Fredun Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Fredun Pharma. - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
-
Fredun Pharma. - Board Meeting Outcome for Outcome Of Board Meeting Dated 15.05.2026
-
Fredun Pharma. - Board Meeting Intimation for The Meeting To Be Held On Monday, 25 May, 2026.
-
Fredun Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Fredun Pharma. - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
-
Fredun Pharma. has submitted to BSE the Shareholding Pattern for the Period Ended April 09, 2026
-
Fredun Pharma. has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026
-
Fredun Pharma. - Disclosure Under Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.
-
Fredun Pharma. - Announcement under Regulation 30 (LODR)-Allotment
-
Fredun Pharma. - Announcement under Regulation 30 (LODR)-Conversion of Securities
-
Fredun Pharma. - Board Meeting Outcome for Outcome Of Board Meeting Dated 09Th April, 2026
-
Fredun Pharma. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Fredun Pharma. has submitted to BSE the Shareholding Pattern for the Period Ended March 25, 2026
-
Fredun Pharma. - Disclosure Under Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015.
-
Fredun Pharma. - Announcement under Regulation 30 (LODR)-Meeting Updates
-
Fredun Pharma. - Announcement under Regulation 30 (LODR)-Allotment
-
Fredun Pharma. - Announcement under Regulation 30 (LODR)-Conversion of Securities
-
Fredun Pharma. - Board Meeting Outcome for Outcome Of Board Meeting Dated 25Th March, 2026
-
Fredun Pharma. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Fredun Pharma. - Announcement under Regulation 30 (LODR)-Meeting Updates
-
Fredun Pharma. - Analyst/Institutional Investors Meeting Held On Wednesday, 11Th March 2026 Organised By Arihant Capital - Bh
-
Fredun Pharma. - Intimation Of Schedule Of 'Bharat Connect Conference', Under The SEBI (Listing Obligations And Disclosure Re
Key fundamentals
Evaluate the intrinsic value of Fredun Pharmaceuticals Ltd stock
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 500.7422 | 307.8076 | 226.9811 | 182.9008 | 120.825 |
| Liabilities | 500.7422 | 307.8076 | 226.9811 | 182.9008 | 120.825 |
| Equity | 5.4727 | 4.7217 | 4.6992 | 4.5323 | 4.4326 |
| Gross Profit | 88.9982 | 52.6457 | 37.9823 | 27.7774 | 13.7953 |
| Net Profit | 33.2069 | 20.8075 | 15.6234 | 10.8066 | 6.3353 |
| Cash From Operating Activities | 30.8131 | -28.8833 | -0.4387 | -14.4088 | -2.3802 |
| NPM(%) | 5.24 | 4.58 | 4.48 | 3.93 | 2.82 |
| Revenue | 633.3265 | 453.8174 | 348.1562 | 274.6756 | 224.4595 |
| Expenses | 544.3283 | 401.1717 | 310.1739 | 246.8982 | 210.6642 |
| ROE(%) | 11.93 | 7.48 | 5.61 | 3.88 | 2.27 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Fredun Pharmaceuticals Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 707.00 | -1.86 | 0.00 | 1326.64 | -26.19 | 0.71 |
| Lotus Eye Hospital and Institute Ltd | 109.00 | 0.74 | 3616.67 | 4834.10 | 3.55 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 17.39 | -0.11 | 0.00 | 10037.19 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 783.65 | -0.52 | 0.00 | 4558.67 | -363.14 | 0.00 |
Company Info
Fredun Pharmaceuticals Ltd is a Public Company incorporated on 08 June 1987. It is classified as Indian Non-Government Company and is registered at Registrar of Companies, Mumbai. It is involved in Manufacture of other chemical products. FREDUN as a group is dedicated to improving lives. Our aim is not profitability, it is effective efficiency. We want our products and services to promote growth and save costs for our customers. 2021-The Company has received a Prestigious and a well-recognized award in the Healthcare Sector 'India's Most Admirable Brand' presented to the Company.2025-The Company acquires Wagr.ai to Enter India & Pet Tech Market-The Company as a leading provider of pharmaceuticals and innovative healthcare solutions for human and veterinary applications-The newly introduced product range, including offerings under MCHC, Functional, Therapeutic, and Grooming categories, has already gained significant praise for its quality and effectiveness.-Fredun Pharma's Freossi Division Marks Its Entry into Sri Lanka with a Suite of Premium Quality Petcare Products.
Fredun Pharmaceuticals Ltd is a Public Company incorporated on 08 June 1987. It is classified as Indian Non-Government Company and is registered at Registrar of Companies, Mumbai. It is involved in Manufacture of other chemical products. FREDUN as a group is dedicated to improving lives. Our aim is not profitability, it is effective efficiency. We want our products and services to promote growth and save costs for our customers. 2021-The Company has received a Prestigious and a well-recognized award in the Healthcare Sector 'India's Most Admirable Brand' presented to the Company.2025-The Company acquires Wagr.ai to Enter India & Pet Tech Market-The Company as a leading provider of pharmaceuticals and innovative healthcare solutions for human and veterinary applications-The newly introduced product range, including offerings under MCHC, Functional, Therapeutic, and Grooming categories, has already gained significant praise for its quality and effectiveness.-Fredun Pharma's Freossi Division Marks Its Entry into Sri Lanka with a Suite of Premium Quality Petcare Products.
Read More
Parent Organisation
Fredun Pharmaceuticals Ltd.
Founded
08/06/1987
Managing Director
Dr.(Mrs.)Daulat N Medhora
NSE Symbol
FAQ
The current price of Fredun Pharmaceuticals Ltd is
The 52-week high for Fredun Pharmaceuticals Ltd is
The market capitalization of Fredun Pharmaceuticals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Fredun Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Fredun Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Fredun Pharmaceuticals Ltd shares.
The CEO of Fredun Pharmaceuticals Ltd is Dr.(Mrs.)Daulat N Medhora, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
